Physician

Thomas G. Sternberg, M.D.

According to 2025 Medicare claims, Thomas Sternberg, M.D. (NPI: 1467448175) practices allergy/immunology in the Bowling Green, KY market, with the plurality of this provider's patient population coming from Warren, KY. This provider's primary affiliated billing organization is GRAVES GILBERT CLINIC PLLC (NPI: 1114948288; TIN: 610700826) and primary practice location at 42101-4000. Sternberg is affiliated with the GGC ValueCare LLC (ACO ID: A5611), participating under the MSSP model.

Sternberg's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 189 traditional Medicare patients, billed 18,273 HCPCS/CPT codes, and received $298,687 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,221 prescription claims across 283 beneficiaries totaling $2,144,980 in drug costs, led by Ilaris (Canakinumab/Pf). DME data shows 144 claims. Open Payments data shows 71 records totaling $2,277. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $78,263 to $298,687. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $661,523 to $2,144,980. In contrast, DME billing represents a smaller volume and moved from a lower plateau to a higher plateau, from $2,075 to $4,210.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	152	4,672	$78,263
2016	181	5,642	$123,114
2017	175	7,300	$112,905
2018	168	6,872	$130,821
2019	174	9,938	$180,842
2020	135	12,464	$237,983
2021	151	13,556	$224,764
2022	171	14,618	$238,274
2023	170	15,432	$210,435
2024	189	18,273	$298,687

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	142	735	$661,523
2016	156	824	$688,019
2017	163	978	$660,291
2018	178	1,271	$927,638
2019	212	1,337	$1,956,946
2020	191	1,474	$2,124,608
2021	221	1,647	$2,439,292
2022	238	1,725	$2,696,078
2023	232	1,934	$2,436,103
2024	283	2,221	$2,144,980

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	99	$82,232
2016	N/R	69	$98,688
2017	N/R	133	$136,982
2018	N/R	142	$127,143
2019	N/R	156	$103,430
2020	N/R	202	$166,467
2021	N/R	184	$168,423
2022	N/R	142	$112,159
2023	N/R	113	$96,828
2024	N/R	144	$117,558

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	81	108	$86
94010	Test to measure expiratory airflow and volume	32	34	$18
96372	Injection of drug or substance under skin or into muscle	36	256	$10
95165	Professional service for preparation and provision of 1 or more antigens	25	287	$9
96160	Administration and interpretation of patient-focused health risk assessment	44	58	$2

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ilaris	Canakinumab/Pf	12	336	$518,029
Nucala	Mepolizumab	60	1,680	$386,147
Xolair	Omalizumab	48	1,344	$190,892
Dupixent Pen	Dupilumab	37	1,036	$148,355
Tezspire	Tezepelumab-Ekko	30	840	$136,445

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J1555	Injection, immune globulin (cuvitru), 100 mg	N	N/R	12	$60,929
J1569	Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg	N	N/R	18	$53,294
A4221	Supplies for maintenance of non-insulin drug infusion catheter, per week (list drugs separately)	N	N/R	19	$1,578
J7626	Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 0.5 mg	N	N/R	25	$807
Q0513	Pharmacy dispensing fee for inhalation drug(s); per 30 days	N	N/R	22	$569

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	71	$2,277	Regeneron Healthcare Solutions, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Thomas G. Sternberg, M.D.?

Tedicare shows public-source Medicare data for Thomas G. Sternberg, M.D. (NPI 1467448175), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Thomas G. Sternberg, M.D. have ACO affiliation data?

Thomas G. Sternberg, M.D. is shown with ACO affiliation data for GGC ValueCare LLC (MSSP, ACO ID A5611).

What billing organization is linked to Thomas G. Sternberg, M.D.?

Thomas G. Sternberg, M.D. is linked to GRAVES GILBERT CLINIC PLLC (billing NPI 1114948288) in the available physician profile data.

Does Thomas G. Sternberg, M.D. have Open Payments data?

Thomas G. Sternberg, M.D. has 71 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.